Health Catalyst, Inc. (NASDAQ:HCAT) Receives $11.50 Average Price Target from Brokerages

Shares of Health Catalyst, Inc. (NASDAQ:HCAT) have been assigned an average recommendation of “Moderate Buy” from the twelve brokerages that are covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $11.50.

Several research analysts recently weighed in on the company. Wells Fargo & Company dropped their price target on Health Catalyst from $14.00 to $13.00 and set an “overweight” rating on the stock in a research report on Friday, May 10th. Evercore ISI dropped their price target on Health Catalyst from $9.00 to $8.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 9th. Cantor Fitzgerald reissued an “overweight” rating and set a $16.00 price target on shares of Health Catalyst in a research report on Tuesday. Stephens dropped their price target on Health Catalyst from $8.00 to $7.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 8th. Finally, Piper Sandler dropped their price target on Health Catalyst from $15.00 to $14.00 and set an “overweight” rating on the stock in a research report on Thursday, June 6th.

Insider Transactions at Health Catalyst

In other news, COO Daniel Lesueur sold 5,209 shares of the company’s stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $6.19, for a total transaction of $32,243.71. Following the completion of the sale, the chief operating officer now owns 150,006 shares in the company, valued at approximately $928,537.14. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In the last quarter, insiders sold 13,035 shares of company stock worth $81,396. 2.70% of the stock is owned by corporate insiders.

Institutional Trading of Health Catalyst

Several large investors have recently made changes to their positions in HCAT. First Light Asset Management LLC boosted its stake in shares of Health Catalyst by 438.5% during the 2nd quarter. First Light Asset Management LLC now owns 3,956,089 shares of the company’s stock worth $25,279,000 after acquiring an additional 3,221,408 shares in the last quarter. Millennium Management LLC boosted its stake in Health Catalyst by 96.3% during the 2nd quarter. Millennium Management LLC now owns 2,413,280 shares of the company’s stock valued at $15,421,000 after purchasing an additional 1,184,131 shares during the period. Kennedy Capital Management LLC bought a new stake in Health Catalyst during the 1st quarter valued at approximately $8,780,000. Primecap Management Co. CA boosted its stake in Health Catalyst by 14.7% during the 2nd quarter. Primecap Management Co. CA now owns 2,379,462 shares of the company’s stock valued at $15,205,000 after purchasing an additional 305,079 shares during the period. Finally, Essex Investment Management Co. LLC bought a new stake in Health Catalyst during the 1st quarter valued at approximately $1,848,000. Institutional investors own 85.00% of the company’s stock.

Health Catalyst Stock Up 3.0 %

Shares of Health Catalyst stock opened at $7.27 on Friday. The stock’s fifty day moving average is $6.67 and its 200-day moving average is $7.11. The firm has a market capitalization of $429.18 million, a PE ratio of -3.93 and a beta of 1.32. Health Catalyst has a 12-month low of $5.42 and a 12-month high of $12.05.

Health Catalyst (NASDAQ:HCAT) last announced its earnings results on Wednesday, August 7th. The company reported $0.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.08 by $0.04. The company had revenue of $75.90 million for the quarter, compared to analyst estimates of $74.96 million. Health Catalyst had a negative return on equity of 11.86% and a negative net margin of 35.56%. Health Catalyst’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.21) earnings per share. Analysts expect that Health Catalyst will post -0.4 EPS for the current year.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.